Real-world evaluation of the effectiveness and predictive factors of anti-PD-1/PD-L1 inhibitors as the first-line therapy for metastatic non-small cell lung cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jing,Chen

第一单位： Department of Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing Cancer Institute, Chongqing Cancer Hospital, Chongqing, 400030, China.

作者： Jing,Chen ^[1] ; Dingyi,Yang ^[1] ; Qianqian,Lei ^[1] ; Yanyan,Long ^[2]

作者单位： Department of Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing Cancer Institute, Chongqing Cancer Hospital, Chongqing, 400030, China. ^[1] Department of Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing Cancer Institute, Chongqing Cancer Hospital, Chongqing, 400030, China. Electronic address: longyanyanlyy30@126.com. ^[2]

主题词人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);肺肿瘤(Lung Neoplasms)

DOI 10.1016/j.asjsur.2023.04.080

PMID 37164823

发布时间 2023-09-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交